These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
939 related articles for article (PubMed ID: 9461515)
1. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515 [TBL] [Abstract][Full Text] [Related]
2. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products induce crosslinking of collagen in vitro. Sajithlal GB; Chithra P; Chandrakasan G Biochim Biophys Acta; 1998 Sep; 1407(3):215-24. PubMed ID: 9748585 [TBL] [Abstract][Full Text] [Related]
4. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637 [TBL] [Abstract][Full Text] [Related]
5. The role of metal-catalyzed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Sajithlal GB; Chithra P; Chandrakasan G Free Radic Biol Med; 1998 Aug; 25(3):265-9. PubMed ID: 9680171 [TBL] [Abstract][Full Text] [Related]
6. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283 [TBL] [Abstract][Full Text] [Related]
8. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645 [TBL] [Abstract][Full Text] [Related]
9. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505 [TBL] [Abstract][Full Text] [Related]
10. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640 [TBL] [Abstract][Full Text] [Related]
11. Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro. Meeprom A; Sompong W; Chan CB; Adisakwattana S Molecules; 2013 May; 18(6):6439-54. PubMed ID: 23722732 [TBL] [Abstract][Full Text] [Related]
12. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789 [TBL] [Abstract][Full Text] [Related]
13. Pathways of formation of glycoxidation products during glycation of collagen. Wells-Knecht MC; Thorpe SR; Baynes JW Biochemistry; 1995 Nov; 34(46):15134-41. PubMed ID: 7578127 [TBL] [Abstract][Full Text] [Related]
14. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N Mol Autism; 2018; 9():3. PubMed ID: 29479405 [TBL] [Abstract][Full Text] [Related]
15. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307 [TBL] [Abstract][Full Text] [Related]
16. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371 [TBL] [Abstract][Full Text] [Related]
18. Cyanidin-3-rutinoside attenuates methylglyoxal-induced protein glycation and DNA damage via carbonyl trapping ability and scavenging reactive oxygen species. Thilavech T; Ngamukote S; Belobrajdic D; Abeywardena M; Adisakwattana S BMC Complement Altern Med; 2016 May; 16():138. PubMed ID: 27215203 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047 [TBL] [Abstract][Full Text] [Related]
20. An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen. Sajithlal GB; Chithra P; Chandrakasan G Mol Cell Biochem; 1999 Apr; 194(1-2):257-63. PubMed ID: 10391148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]